CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 116.10M |
| Enterprise value | -21.31M |
| Trailing P/E | 7.10 |
| Forward P/E | 14.90 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.97 |
| Price/book (mrq) | 5.04 |
| Enterprise value/revenue | -0.16 |
| Enterprise value/EBITDA | 3.86 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.06 |
| 52-week change 3 | -13.79% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 5.8500 |
| 52-week low 3 | 1.0400 |
| 50-day moving average 3 | 1.5148 |
| 200-day moving average 3 | 1.6985 |
Share statistics
| Avg vol (3-month) 3 | 7.02M |
| Avg vol (10-day) 3 | 559.46k |
| Shares outstanding 5 | 77.92M |
| Implied shares outstanding 6 | 77.92M |
| Float 8 | 58.39M |
| % held by insiders 1 | 0.95% |
| % held by institutions 1 | 72.57% |
| Shares short (15 Jul 2024) 4 | 7.74M |
| Short ratio (15 Jul 2024) 4 | 4.86 |
| Short % of float (15 Jul 2024) 4 | 10.00% |
| Short % of shares outstanding (15 Jul 2024) 4 | 9.93% |
| Shares short (prior month 14 Jun 2024) 4 | 7.76M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 13.87% |
| Operating margin (ttm) | 28.11% |
Management effectiveness
| Return on assets (ttm) | 3.23% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 119.18M |
| Revenue per share (ttm) | 1.53 |
| Quarterly revenue growth (yoy) | 76.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 12.87M |
| Net income avi to common (ttm) | 16.53M |
| Diluted EPS (ttm) | 0.2100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 150.28M |
| Total cash per share (mrq) | 1.93 |
| Total debt (mrq) | 12.87M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.16 |
| Book value per share (mrq) | -0.47 |
Cash flow statement
| Operating cash flow (ttm) | -91.43M |
| Levered free cash flow (ttm) | -471.75k |
© 2024 Yahoo. All rights reserved.